Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests. Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
Annual jab for HIV protection passes trial hurdle
March 12, 2025
- Exotic fruit beneficial for anyone struggling with cholesterol and diabetes
- For Patients Needing Transplants, Hope Arrives on Tiny Hooves
- Kennedy Links Measles Outbreak to Poor Diet and Health, Citing Fringe Theories
- Strong Scientific Leaders Must Speak Out against the Trump Administration’s Science Denial
Headlines
